1. American Cancer Society (ACS) 2020 Family cancer syndromes. https://www.cancer.org/cancer/cancer-causes/genetics/family-cancer-syndromes.html
2. Godet I, Gilkes DM. (2017) BRCA1 and BRCA2 mutations and treatment strategies for breast cancer. Integr Cancer Sci Ther. 4(1):10. https://dx.doi.org/10.15761%2FICST.1000228
3. Mersch J, Jackson MA, Park M, et al. (2015) Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer. 121(14):269-275. https://doi.org/10.1002/cncr.29357
4. Kuchenbaecker KB, Hopper JL, Barnes DR, et al. (2017) Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA. 317(23):2402-2416. https://doi.org/10.1001/jama.2017.7112
5. Song Y, Barry WT, Seah DS, Tung NM, Garber JE, Lin NU. (2020) Patterns of recurrence and metasasis in BRCA1/BRCA2-associated breast cancers. Cancer. 126(2):271-280. https://doi.org/10.1002/cncr.32540
6. Haque R, Shi JM, Telford C, et al. (2018) Survival outcomes in BRCA1 or BRCA2 mutation carriers and the influence of triple-negative breast cancer subtype. Perm J. 22:170-197. https://dx.doi.org/10.7812%2FTPP%2F17-197
7. Lafourcade A, His M, Baglietto L, Boutron-Ruault MC, Dossus L, Rondeau V. (2018) Factors associated with breast cancer recurrences or mortality and dynamic prediction of death using history of cancer recurrences: The French E3N cohort. BMC Cancer. 18:171. https://doi.org/10.1186/s12885-018-4076-4
8. Mau C, Untch M. (2017) Prophylactic surgery: For whom, when and how. Breast Care. 12:379-384. https://doi.org/10.1159/000485830
9. Ludwig KK, Neuner J, Butler A, Geurts JL, Kong AL. (2016) Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. Am J Surg. 212(4):660-669. https://doi.org/10.1016/j.amjsurg.2016.06.010
10. van Zelst JCM, Mus RDM, Woldringh G, et al. (2017) Surveillance of women with the BRCA1 or BRCA2 mutation by using biannual automated breast US, MR imaging, and mammography. Radiol. 285(2):376-388. https://doi.org/10.1148/radiol.2017161218
11. Nanez A, Stram DA, Garcia C, Powell CB. (in press) Ovarian cancer surveillance in the clinical follow up of women with known BRCA1 or BRCA2 pathogenic variants in a large health care system. Gynecol Oncol. https://doi.org/10.1016/j.ygyno.2021.07.034
12. Boghosian T, McCuaig JM, Carlsson L, Metcalfe KA. (2021) Psychosocial interventions for women with a BRCA1 or BRCA2 mutation: A scoping review. Cancers. 13(7):1486. https://doi.org/10.3390/cancers13071486
13. Glassey R, O'Connor M, Ives A, et al. (2018) Heightened perception of breast cancer risk in young women at risk of familial breast cancer. Fam Cancer. 17:15-22. https://doi.org/10.1007/s10689-017-0001-2
14. Ringwald J, Wochnowski C, Bosse K, et al. (2016) Psychological distress, anxiety, and depression of cancer-affected BRCA1/2 mutation carriers: A systematic review. J Genet Couns. 25(5):880-891. https://doi.org/10.1007/s10897-016-9949-6
15. Gopie JP, Vasen HFA, Tibben A. (2012) Surveillance for hereditary cancer: Does the benefit outweigh the psychological burden? A systematic review. Crit Rev Oncol Hematol. 83(3):329-340. https://doi.org/10.1016/j.critrevonc.2012.01.004
16. Borreani C, Manoukian S, Bianchi E, et al. (2013) The psychological impact of breast and ovarian cancer preventive options in BRCA1 and BRCA2 mutation carriers. Clin Genet. 85(1):7-15. https://doi.org/10.1111/cge.12298
17. Harmsen MG, Hermens RPMG, Prins JB, Hoogerbrugge N, de Hullu JA. (2015) How medical choices influence quality of life of women carrying a BRCA mutation. Crit Rev Oncol Hematol. 96(3):555-568. https://doi.org/10.1016/j.critrevonc.2015.07.010
18. Razdan SN, Patel V, Jewell S, McCarthy CM. (2016) Quality of life among patients 95 after bilateral prophylactic mastectomy: A systematic review of patient-reported outcomes. Qual Life Res. 25(6):1409-1421. https://doi.org/10.1007/s11136-015-1181-6
19. D'Alonzo M, Piva E, Pecchio S, et al. (2018) Satisfaction and impact on quality of life of clinical and instrumental surveillance and prophylactic surgery in BRCA-mutation carriers. Clin Breast Cancer. 18(6):e1361-e1366. https://doi.org/10.1016/j.clbc.2018.07.015
20. Manoukian S, Alfieri S, Bianchi E, Peissel B, Azzollini J, Borreani C. (2019) Risk-reducing surgery in BRCA1/BRCA2 mutation carriers: Are there factors associated with the choice? Psycho-Oncology. 28(9):1871-1878. https://doi.org/10.1002/pon.5166
21. Young JL, Werner-Lin A, Mueller R, Hoskins L, Epstein N, Greene MH. (2017) Longitudinal cancer risk management trajectories of BRCA1/2 mutation-positive reproductive-age women. J Psychosoc Oncol. 35(4):393-408. https://doi.org/10.1080/07347332.2017.1292574
22. Rush SK, Norquist B, Laurino M, et al. (2020) Cancer worry and decision making about risk reduction in women with BRCA1 and BRCA2 mutations. Gynecol Oncol. 156(3):E29. https://doi.org/10.1016/j.ygyno.2019.11.090
23. Dean M, Scherr, C. L., Clements, M., Koruo, R., Martinez, J., & Ross, A. (2017) “When information is not enough”: A model for understanding BRCA-positive previvors’ information needs regarding hereditary breast and ovarian cancer risk. Patient Educ Couns. 100(9):1738-1743. https://doi.org/10.1016/j.pec.2017.03.013
24. Hoberg-Vetti H, Bjorvatn C, Fiane BE, et al. (2016) BRCA1/2 testing in newly diagnosed breast and ovarian cancer patients without prior genetic counseling: The DNA-BONus study. Eur J Hum Genet. 24:881-888. https://doi.org/10.1038/ejhg.2015.196
25. Mella S, Muzzatti B, Dolcetti R, Annunziata MA. (2017) Emotional impact on the results of BRCA1 and BRCA2 genetic test: An observational retrospective study. Hered Cancer Clin Pract. 15:16. https://doi.org/10.1186/s13053-017-0077-6
26. den Heijer M, Seynaeve C, Vanheusden K, et al. (2012) Long-term psychological distress in women at risk for hereditary breast cancer adhering to regular surveillance: A risk profile. Psycho-Oncology. 22(3):598-604. https://doi.org/10.1002/pon.3039
27. Cannioto R. (2020) Investigating contributions of physical inactivity and obesity to racial disparities in cancer risk and mortality warrants more consideration. JNCI. 113(6):647-649. https://doi.org/10.1093/jnci/djaa189
28. Williams CD, Bullard AJ, O'Leary M, Thomas R, Redding IV TS, Goldstein K. (2018) Racial/ethnic disparities in BRCA counseling and testing: A narrative review. J Racial Ethn Health Disparities. 6:570-583. https://doi.org/10.1007/s40615-018-00556-7
29. Jones T, Freeman K, Ackerman M, et al. (2020) Mental illness and BRCA1/2 genetic testing intention among multiethnic women undergoing screening mammography. Oncol Nurs Forum. 47(1):E13-E24. https://doi.org/10.1188/20.onf.e13-e24
30. Jones T, Trivedi MS, Jiang X, et al. (2019) Racial and ethnic differences in BRCA1/2 and multigene panel testing among young breast cancer patients. J Cancer Educ. 36(3):463-469. https://doi.org/10.1007/s13187-019-01646-8
31. Facing Our Risk of Cancer Empowered (FORCE) (2021) Support - Message boards. https://www.facingourrisk.org/support/message-boards
32. Harris PA, Taylor R, Minor BL, et al. (2019) The REDCap consortium: Building an international community of software platform partners. J Biomed Inform, 95:103208. https://doi.org/10.1016/j.jbi.2019.103208
33. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. (2009) Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 42(2):377-381. https://doi.org/10.1016/j.jbi.2008.08.010
34. US Census Bureau (2021) How the Census Bureau measures poverty. https://www.census.gov/topics/income-poverty/poverty/guidance/poverty-measures.html
35. Lowe B, Decker O, Muller S, et al. (2008) Validation and standardization of the Generalized Anxiety Disorder screener (GAD-7) in the general population. Med Care. 46(3):266-274. https://doi.org/10.1097/mlr.0b013e318160d093
36. Delgado AJ, Gordon D, Schnarrs P. (2016) The effect of discrimination and stress on sexual and behavioral health among sexual minority servicemen. Journal of Gay and Lesbian Mental Health. 20(3):258-279. https://doi.org/10.1080/19359705.2016.1141344
37. Spitzer RL, Kroenke K, Williams JBW. (2006) A brief measure for assessing generalized anxiety disorder. Arc Intern Med. 166(10):1092-1097. https://doi.org/10.1001/archinte.166.10.1092
38. Kroenke K, Spitzer RL, Williams JBW. (2001) The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 16(9):606-613. https://dx.doi.org/10.1046%2Fj.1525-1497.2001.016009606.x
39. Stata Statistical Software: Release 16 (2019) Version 16. Cary, NC.
40. Nelson HD, Pappas M, Cantor A, Haney E, Holmes R. (2019) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: Updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 322(7):666-685. https://doi.org/10.1001/jama.2019.8430
41. Moses T, Landefeld R. (2018) Addressing behavioral health and cancer in Hispanic/Latino populations. https://www.bhthechange.org/resources/addressing-behavioral-health-and-cancer-in-hispanic-latino-populations/
42. Yeomans Kinney A, Gammon A, Coxworth J, Simonsen SE, Arce-Laretta M. (2010) Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1/2 mutation testing and preventive strategies. Genet Medicine. 12(2):105-115. https://doi.org/10.1097/gim.0b013e3181c9af2d
43. Parente DJ. (2020) BRCA-related cancer genetic counseling is indicated in many women seeking primary care. J Am Board Fam Med. 33(6):885-893. https://doi.org/10.3122/jabfm.2020.06.190461
44. Thompson HS, Sussner K, Schwartz MD, et al. (2012) Receipt of genetic counseling recommendations among black women at high risk for BRCA mutations. Genet Test Mol Biomarkers. 16(11):1257-1262. https://doi.org/10.1089/gtmb.2012.0114
45. Levy DE, Byfield SD, Comstock CB, et al. (2011) Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk. Genet Med. 13(4):349-355. https://doi.org/10.1097/gim.0b013e3182091ba4
46. McGuinness JE, Trivedi MS, Silverman T, et al. (2019) Uptake of genetic testing for germline BRCA1/2 pathogenic variants in a predominantly Hispanic population. Cancer Genet. 235-236:72-76. https://doi.org/10.1016/j.cancergen.2019.04.063
47. Lagos-Jaramillo VI, Press MF, Ricker CN, Dubeau L, Mai PL, Weitzel JN. (2011) Pathological characteristics of BRCA-associated breast cancers in Hispanics. Breast Cancer Res Treat. 130:281-289. https://doi.org/10.1007/s10549-011-1570-7
48. Hull LE, Haas JS, Simon SR. (2018) Provider discussions of genetic tests with U.S. women at right for a BRCA mutation. Am J Prev Med. 54(2):221-228. https://doi.org/10.1016/j.amepre.2017.10.015
49. Guo F, Scholl M, Fuchs EL, Wong R, Kuo YF, Berenson AB. (2020) Trends in positive BRCA test results among older women in the United States, 2008-2018. JAMA Network Open. 3(11):e2024358. http://jamanetwork.com/article.aspx?doi=10.1001/jamanetworkopen.2020.24358
50. Rubinsak LA, Kleinman A, Quillin J, et al. (2019) Awareness and acceptability of population-based screening for pathogenic BRCA variants: Do race and ethnicity matter? Gynecol Oncol. 154(2):383-387. https://doi.org/10.1016/j.ygyno.2019.06.009
51. Hurtado-de-Mendoza A, Graves K, Gomez-Trillos S, et al. (2018) Provider's perceptions of barriers and facilitators for Latinas to participate in genetic cancer risk assessment for hereditary breast and ovarian cancer. Healthcare. 6(3):116. https://doi.org/10.3390/healthcare6030116
52. American Cancer Society (ACS) (2018) Cancer facts and figures for Hispanics/Latinos 2018-2020. https://www.cancer.org/research/cancer-facts-statistics/hispanics-latinos-facts-figures.html
53. Sussner KM, Jandorf L, Thompson HS, Valdimarsdottir HB (2013) Barriers and facilitators to BRCA genetic counseling among at-risk Latinas in New York City. Psycho-Oncology. 22(7):1594-1604. https://doi.org/10.1002/pon.3187
54. Sussner KM, Jandorf L, Thompson HS, Valdimarsdottir HB. (2010) Interest and beliefs about BRCA genetic counseling among at-risk Latinas in New York City. J Genet Couns. 19(3):255-268. https://doi.org/10.1007/s10897-010-9282-4
55. Augusto B, Kasting ML, Couch FJ, Lindor NM, Vadaparampil ST. (2019) Current approaches to cancer genetic counseling services for Spanish-speaking patients. J Immigr Minor Health. 21(2):434-437. https://doi.org/10.1007/s10903-018-0772-z
56. Hamilton JG, Shuk E, Arniella G, et al. (2016) Genetic testing awareness and attitudes among Latinos: Exploring shared perceptions and gender-based differences. Public Health Genomics. 19(1):34-46. https://dx.doi.org/10.1159%2F000441552
57. Trottier M, Lunn J, Butler R, et al. (2014) Strategies for recruitment of relatives of BRCA mutation carriers to a genetic testing program in the Bahamas. Clin Genet. 88(2):182-186. https://doi.org/10.1111/cge.12468
58. Houlihan MC, Tariman JD. (2017) Comparison of outcome measures for traditional and online support groups for breast cancer patients: An integrative literature review. J Adv Pract Oncol. 8(4):348-359. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040879/